MENU
+Compare
VNRX
Stock ticker: ASE
AS OF
Jul 3 closing price
Price
$0.74
Change
-$0.01 (-1.33%)
Capitalization
62.13M

VNRX VolitionRX Limited Forecast, Technical & Fundamental Analysis

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19... Show more

VNRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for VNRX with price predictions
Jul 03, 2025

VNRX's RSI Indicator leaves overbought zone

The 10-day RSI Indicator for VNRX moved out of overbought territory on June 24, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 20 instances where the indicator moved out of the overbought zone. In of the 20 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 54 cases where VNRX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for VNRX turned negative on July 02, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 54 similar instances when the indicator turned negative. In of the 54 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VNRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

VNRX broke above its upper Bollinger Band on June 20, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

VNRX moved above its 50-day moving average on May 30, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for VNRX crossed bullishly above the 50-day moving average on June 03, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +4 3-day Advance, the price is estimated to grow further. Considering data from situations where VNRX advanced for three days, in of 220 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 63 cases where VNRX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. VNRX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.331) is normal, around the industry mean (24.348). P/E Ratio (0.000) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (70.922) is also within normal values, averaging (42.660).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VNRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
VNRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

VNRX is expected to report earnings to fall 23.33% to -4 cents per share on August 13

VolitionRX Limited VNRX Stock Earnings Reports
Q2'25
Est.
$-0.05
Q1'25
Missed
by $0.02
Q4'24
Est.
$-0.05
Q3'24
Est.
$-0.07
Q2'24
Beat
by $0.01
The last earnings report on May 16 showed earnings per share of -5 cents, missing the estimate of -3 cents. With 235.76K shares outstanding, the current market capitalization sits at 62.13M.
A.I. Advisor
published General Information

General Information

a development stage life sciences company

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Or Nursing Services
Address
1489 West Warm Springs Road
Phone
+1 646 650-1351
Employees
110
Web
https://www.volition.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PILBF1.010.09
+9.60%
PILBARA MINERALS LTD
CLSZF0.02N/A
N/A
China Oil & Gas Group, Ltd.
JGCCY15.91N/A
N/A
JGC Holdings Corporation
FSGB9.50N/A
N/A
First Federal of South Carolina Federal Savings Bank
SUNPF0.14-0.01
-6.58%
SUN PEAK METALS CORP.

VNRX and Stocks

Correlation & Price change

A.I.dvisor tells us that VNRX and STRRP have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VNRX and STRRP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VNRX
1D Price
Change %
VNRX100%
-1.53%
STRRP - VNRX
27%
Poorly correlated
+1.09%
SRDX - VNRX
25%
Poorly correlated
+3.41%
VAPO - VNRX
25%
Poorly correlated
N/A
IMDX - VNRX
24%
Poorly correlated
-6.25%
RMD - VNRX
23%
Poorly correlated
+0.42%
More